# Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function

> **NCT02584075** · PHASE4 · UNKNOWN · sponsor: **Beijing Chao Yang Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Coronary Endothelial Function

## Interventions

- **DRUG:** Byetta (Exenatide)
- **DRUG:** Glucophage ( Metformin Hydrochloride)

## Key facts

- **NCT ID:** NCT02584075
- **Lead sponsor:** Beijing Chao Yang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2017-11
- **Final completion:** 2018-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02584075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02584075, "Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02584075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*